Hubei Cancer Hospital
In research, Hubei Cancer Hospital stands highest in Medicine (#3,182 of 10,443 worldwide), Health Sciences (#4,426 of 11,982 worldwide) and Life Sciences (#2,897 of 7,800 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology and Pulmonary and Respiratory Medicine — Oncology is 17.0× its share of world research.
- World rank, 2022–2025
- #6,272 of 28,054 · #11,805 all time
- Rank in China
- #1,314 of 3,058
- Research works
- 953 ▲ 89% vs 2013–17
- Citations
- 12k 12.9 per fractional work
- Top-10% rate
- 22.1% record average 16.5%
- Open access
- 52% world 28%
What is Hubei Cancer Hospital known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #3,182 of 10,443 | 20.6% | 184 | #5666 | |
| Health SciencesDomain | #4,426 of 11,982 | 20.4% | 189 | #7506 | |
| Life SciencesDomain | #2,897 of 7,800 | 25.7% | 79 | #5952 |
Each strip is that field’s whole ranked pool, with the notch where Hubei Cancer Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Medicine#5,666 #3,182
- Health Sciences#7,506 #4,426
- Life Sciences#5,952 #2,897
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Hubei Cancer Hospital specialise in?
Where its research is concentrated relative to its size: Oncology takes 17.0× the share of its output that it takes of world research.
- OncologySubfield · 56.1 works17×
- Pulmonary and Respiratory MedicineSubfield · 35.6 works7.9×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.4×. Every wedge is a field page.
- Immunology and Microbiology 4.4×
- Biochemistry, Genetics and Molecular Biology 3.8×
- Medicine 3.3×
- Pharmacology, Toxicology and Pharmaceutics 1.2×
- Neuroscience 0.9×
- Nursing 0.6×
- Dentistry 0.5×
- Materials Science 0.4×
- Health Professions 0.4×
- Physics and Astronomy 0.3×
- Decision Sciences 0.2×
- Engineering 0.2×
- Psychology 0.2×
- Chemistry 0.2×
- Computer Science 0.1×
- Agricultural and Biological Sciences 0.1×
- Economics, Econometrics and Finance 0.1×
- Mathematics 0.1×
- Environmental Science 0.1×
- Energy 0.0×
- Social Sciences 0.0×
- Earth and Planetary Sciences 0.0×
- Arts and Humanities 0.0×
Who are the top researchers at Hubei Cancer Hospital?
Ranked on the composite score, Yi Huang, Yanping Hu and Xinhong Wu lead among researchers whose main affiliation is Hubei Cancer Hospital.
- 1 Yi Huang China · #586,879 worldwide 38 citations · 24 works
- 2 Yanping Hu China · #918,575 worldwide 81 citations · 23 works
- 3 Xinhong Wu China · #1,086,862 worldwide 31 citations · 15 works
- 4 Sheng Hu China · #1,442,289 worldwide 17 citations · 15 works
Which keywords describe research at Hubei Cancer Hospital?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Chemotherapy, Tumor Microenvironment, Immunotherapy, Metastasis, Gene Expression, Radiotherapy and Clinical Practice Guidelines.
- CAR T Cells
- Leukemia
- GPX4
- Biogenesis
- Lipid Peroxidation
- Tumor Markers
- Adjuvant Therapy
- Prognostic Markers
- Cancer Immunotherapy
- Cell Death
- Neoadjuvant Therapy
- Immune Checkpoint Blockade
- Survival Analysis
- Oxidative Stress
- Targeted Therapy
- Clinical Trials
- Radiotherapy
- Metastasis
- Immunotherapy
- Chemotherapy
- Cancer
- Tumor Microenvironment
- Inflammation
- Gene Expression
- Clinical Practice Guidelines
- Biomarkers
- Prognostic Factors
- Quality of Life
- Breast Cancer
- PD-1 and PD-L1
- Cancer Therapy
- Tumor Regression
- Immunity
- Lymphoma
- Prognosis
- Epigenetic Regulation
- Molecular Characterization
- Ferroptosis
- Endoscopic Resection
- Survival
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer36▲ 9.1×39 topics
- Chemotherapy36▲ 17×21 topics
- Tumor Microenvironment29▲ 22×8 topics
- Immunotherapy25▲ 12×15 topics
- Inflammation22▲ 3.6×50 topics
- Metastasis18▲ 18×12 topics
- Gene Expression16▲ 9.2×11 topics
- Radiotherapy16▲ 14×11 topics
- Clinical Practice Guidelines16▲ 10×12 topics
- Clinical Trials15▲ 7.8×8 topics
- Biomarkers15▲ 7.5×13 topics
- Targeted Therapy14▲ 22×5 topics
- Prognostic Factors14▲ 11×13 topics
- Oxidative Stress13▲ 2.8×37 topics
- Quality of Life12▲ 2.8×21 topics
- Survival Analysis12▲ 15×6 topics
- Breast Cancer12▲ 17×9 topics
- Immune Checkpoint Blockade11▲ 34×1 topic
- PD-1 and PD-L111▲ 34×1 topic
- Neoadjuvant Therapy10▲ 14×5 topics
- Cancer Therapy9▲ 5.5×15 topics
- Cell Death9▲ 13×6 topics
- Tumor Regression9▲ 27×2 topics
- Cancer Immunotherapy9▲ 19×3 topics
- Immunity8▲ 7.2×5 topics
- Prognostic Markers8▲ 27×3 topics
- Lymphoma8▲ 18×4 topics
- Adjuvant Therapy8▲ 22×2 topics
- Prognosis8▲ 7.9×6 topics
- Tumor Markers7▲ 31×2 topics
- Epigenetic Regulation7▲ 11×4 topics
- Lipid Peroxidation7▲ 23×2 topics
- Molecular Characterization7▲ 14×5 topics
- Biogenesis7▲ 13×3 topics
- Ferroptosis7▲ 30×1 topic
- GPX47▲ 30×1 topic
- Endoscopic Resection7▲ 23×2 topics
- Leukemia6▲ 26×2 topics
- Survival6▲ 16×3 topics
- CAR T Cells6▲ 29×1 topic
Which research topics does Hubei Cancer Hospital publish most on?
By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Ferroptosis and cancer prognosis, CAR-T cell therapy research and Lung Cancer Treatments and Mutations.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 11 works
- 2 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 7 works
- 3 CAR-T cell therapy research Oncology 6 works
- 4 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 6 works
- 5 Lung Cancer Research Studies Oncology 6 works
- 6 RNA modifications and cancer Molecular Biology 5 works
- 7 Cancer-related molecular mechanisms research Cancer Research 5 works
- 8 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 4 works
- 9 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 4 works
- 10 Thyroid Cancer Diagnosis and Treatment Endocrinology, Diabetes and Metabolism 4 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Hubei Cancer Hospital's research output changed?
Output in 2018–2022 was 89% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Wuhan
- Huazhong University of Science and Technology
- Wuhan University
- Wuhan University of Technology
- China University of Geosciences
- Huazhong Agricultural University
- Central China Normal University
- Wuhan University of Science and Technology
- Naval University of Engineering
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.